FDAnews
www.fdanews.com/articles/159800-senesco-opens-new-clinical-trial-site-at-seattle-cancer-care-alliance

Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance

October 28, 2013
Senesco has enrolled its first patients at a new clinical trial site in Seattle. The company is beginning a Phase Ib/IIa trial of its SNS01-T drug for B-cell cancer.
Pharmaceutical Business Review